12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·2 days ago, 12:07 PMCDT-16.56%JSPR+3.23%
U.S. stock market midday update: JSPR plummets 13.32%: Earnings report exceeds expectations but fails to save the market, sector weakness drags down stock pricePrice Alert·Aug 18 at 03:53 PMJSPR+3.23%
Jasper Therapeutics, Inc. 2Q 2026: Net loss $(2.8M), EPS $(0.10) — 10-Q SummaryTradingView·Aug 14 at 03:11 PMJSPR+3.23%
Jasper Therapeutics Q2 FY26 net loss narrows to $2.76 million; R&D expense drops to $5.14 millionPUBT·Aug 14 at 03:00 PMJSPR+3.23%KPRX0.00%
Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | JSPR Stock NewsStockTitan·Aug 14 at 07:00 AMJSPR+3.23%
U.S. stock market quick update: JSPR down 9.07%! Analysts support KP-104, why is the market not buying it?Price Alert·Aug 12 at 07:44 PMJSPR+3.23%
Inside the Under-the-Radar Reshuffle Across Tech and Defensive AssetsGlobal Report·Aug 12 at 10:12 AMCLBT-4.10%VERI+10.01%
Biren Amin Initiates Buy on Jasper Therapeutics, Highlighting KP-104’s Differentiated Dual-Pathway Mechanism and $1.5B Peak Sales Potential in Kidney DiseasesTip Ranks·Aug 12 at 09:45 AMJSPR+3.23%
